1	Mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	0-5	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
2	de	de	SPS00	C0332285	atributo	6-8	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
3	32	32		-	-	9-11	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
5	con	con	SPS00	C0332287	atributo	17-20	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
6	parálisis	parálisis	NCFN000	C0007789_1	trastorno_1	21-30	101_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
7	cerebral	cerebral	NCCS000	C0007789_2	trastorno_2	31-39	101_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-	6	1543	LOC
8	del	del	SP+DA	-	-	40-43	101_QUEST_clinical_caseMIR	SENT1	B-Calificador	-	6	1543	Modif
9	parto	parto	NCMS000	C1148523	entidad_observable	44-49	101_QUEST_clinical_caseMIR	SENT1	I-Calificador	-	8	97	MultiE
10	que	que	PR0CN000	-	-	50-53	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
11	acude	acudir	VMIP3S0	-	-	54-59	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
12	a	a	SPS00	-	-	60-61	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
13	Urgencias	urgencia	NCFP000	C0439609	calificador	62-71	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
14	por	por	SPS00	C0678226	atributo	72-75	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
15	cuadro	cuadro	NCMS000	-	-	76-82	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
16	de	de	SPS00	C0332285	atributo	83-85	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
17	orinas	orina	NCFP000	C0042036	sustancia	86-92	101_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
18	oscuras	oscuro	AQ0FP0	C0332582	calificador	93-100	101_QUEST_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-	17	164	MultiE
19	de	de	SPS00	C0332285	atributo	101-103	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
20	unos	uno	DI0MP0	C0205447	calificador	104-108	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
21	días	día	NCMP000	C0439228#C0332169	calificador	109-113	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
22	de	de	SPS00	C0332285	atributo	114-116	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
23	evolución	evolución	NCFS000	-	-	117-126	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
24	en	en	SPS00	C1720294#C0332285	calificador#atributo	127-129	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
25	relación	relación	NCFS000	C0456603#C0439849#C3645603	calificador#atributo#metadato_fundacional	130-138	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
26	con	con	SPS00	C0332287	atributo	139-142	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
27	episodio	episodio	NCMS000	C0332189#C1455761_1	atributo_1	143-151	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
28	de	de	SPS00	C0332189#C1455761_2	atributo_2	152-154	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
29	fiebre	fiebre	NCFS000	C0015967	hallazgo	155-161	101_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
30	alta	alto	AQ0FS0	C0205250	calificador	162-166	101_QUEST_clinical_caseMIR	SENT1	B-Calificador	-	29	1543	Modif
31	y	y	CC	C1706368	calificador	167-168	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
32	tos	tos	NCFS000	C0850149_1	hallazgo_1	169-172	101_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
33	seca	seco	AQ0FS0	C0850149_2	hallazgo_2	173-177	101_QUEST_clinical_caseMIR	SENT1	B-Calificador	-	32	1543	Modif
34	.	.	Fp	-	-	177-178	101_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-

1	Al	al	SP+DA	-	-	179-181	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
2	ingreso	ingreso	NCMS000	-	-	182-189	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
3	se	se	P00CN000	-	-	190-192	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
4	objetiva	objetivar	VMIP3S0	-	-	193-201	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
5	en	en	SPS00	C1720294#C0332285	calificador#atributo	202-204	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
6	hemograma	hemograma	NCMS000	C0200631	procedimiento	205-214	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
7	16900	16900		-	-	215-220	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
8	leucocitos/mm3	leucocitos/mm3		-	-	221-235	101_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-	-	-	-
9	(	(	Fpa	-	-	236-237	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
10	85	85	Z	-	-	237-239	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
11	%	%	Ft	-	-	239-240	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
12	S	s	NCFS000	-	-	241-242	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
13	,	,	Fc	-	-	242-243	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
14	11	11	Z	-	-	244-246	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
15	%	%	Ft	-	-	246-247	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
16	L	l	NCFS000	-	-	248-249	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
17	,	,	Fc	-	-	249-250	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
18	4	4	Z	-	-	251-252	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
19	%	%	Ft	-	-	252-253	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
20	M	m	NCFS000	-	-	254-255	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
21	)	)	Fpt	-	-	255-256	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
22	,	,	Fc	-	-	256-257	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
23	hemoglobina	hemoglobina	NCFS000	C0019046	sustancia	258-269	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
24	de	de	SPS00	C0332285	atributo	270-272	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
25	6.3	6.3	Z	-	-	273-276	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
26	gr	g	NC00SC0	-	-	277-279	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
27	/	/	Fh	-	-	279-280	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
28	dl	decilitro	NCMN000	C0439241	calificador	280-282	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
29	;	;	Fx	-	-	282-283	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
30	VCM	vcm	NC00SC0	C0524587	entidad_observable	284-287	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
31	109	109		-	-	288-291	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
32	fl	fl	NC00SC0	C0475213	calificador	292-294	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
33	,	,	Fc	-	-	294-295	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
34	360000	360000		-	-	296-302	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
35	plaquetas/mm3	plaquetas/mm3		-	-	303-316	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
36	.	.	Fp	-	-	316-317	101_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	318-320	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
2	la	el	DA0FS0	-	-	321-323	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
3	bioquímica	bioquímico	NCFS000	C0205474#C0175854	calificador#ocupación	324-334	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
4	LDH	ldh	NC00SC0	C0022917	sustancia	335-338	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
5	2408	2408		-	-	339-343	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
6	;	;	Fx	-	-	343-344	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
7	bilirrubina	bilirrubina	NCFS000	C0005437	sustancia	345-356	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
8	6.8	6.8	Z	-	-	357-360	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
9	mg	mg	NCMN000	-	-	361-363	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
10	/	/	Fh	-	-	363-364	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
11	dl	decilitro	NCMN000	C0439241	calificador	364-366	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
12	,	,	Fc	-	-	366-367	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
13	(	(	Fpa	-	-	368-369	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
14	bilirrubina	bilirrubina	NCFS000	C0301719_1	sustancia_1	369-380	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
15	no	no	RN	C0301719_2	sustancia_2	381-383	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
16	conjugada	conjugar	VMP00SF	C0301719_3	sustancia_3	384-393	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
17	6.1	6.1	Z	-	-	394-397	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
18	mg	mg	NCMN000	-	-	398-400	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
19	/	/	Fh	-	-	400-401	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
20	dl	decilitro	NCMN000	C0439241	calificador	401-403	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
21	)	)	Fpt	-	-	403-404	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
22	,	,	Fc	-	-	404-405	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
23	GOT	glutámic_oxaloacetic_transaminase_(transaminasa_glutámico_oxalacética)	NC00YL0	-	-	406-409	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
24	y	y	CC	C1706368	calificador	410-411	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
25	GPT	glutamic_pyruvic_transaminase_(transaminasa_glutámico_pirúvica)	NC00YL0	-	-	412-415	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
26	normales	normal	AQ0CP0	C0205307	calificador	416-424	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
27	.	.	Fp	-	-	424-425	101_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	426-428	101_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
2	el	el	DA0MS0	-	-	429-431	101_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
3	estudio	estudio	NCMS000	C0557651	medio_ambiente	432-439	101_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
4	morfológico	morfológico	AQ0MS0	-	-	440-451	101_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
5	de	de	SPS00	C0332285	atributo	452-454	101_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
6	sangre	sangre	NCFS000	C0005767	sustancia	455-461	101_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
7	se	se	P00CN000	-	-	462-464	101_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
8	observa	observar	VMIP3S0	-	-	465-472	101_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
9	anisocitosis	anisocitosis	NCFN000	C0221278	anomalía_morfológica	473-485	101_QUEST_clinical_caseMIR	SENT4	B-Grp_Enfermedad	-	16	1546	Causada_por
10	macrocítica	macrocítico	AQ0FS0	-	-	486-497	101_QUEST_clinical_caseMIR	SENT4	B-Calificador	-	9	1546	Modif
11	con	con	SPS00	C0332287	atributo	498-501	101_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
12	frecuentes	frecuente	AQ0CP0	C0332183	calificador	502-512	101_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
13	formas	forma	NCFP000	C0348078	atributo	513-519	101_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
14	esferocitadas	esferocitadas	VMP00PF	-	-	520-533	101_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
15	y	y	CC	C1706368	calificador	534-535	101_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
16	policromatofilia	policromatofilia	NCFS000	C0333942	anomalía_morfológica	536-552	101_QUEST_clinical_caseMIR	SENT4	B-Grp_Enfermedad	-	9	1546	Causada_por
17	sin	sin	SPS00	C0332288	atributo	553-556	101_QUEST_clinical_caseMIR	SENT4	B-Calificador	-	16	1546	Modif
18	blastos	blastos	NCMP000	-	-	557-564	101_QUEST_clinical_caseMIR	SENT4	I-Calificador	Negacion	17	164	MultiE
19	.	.	Fp	-	-	564-565	101_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-

1	El	el	DA0MS0	-	-	566-568	101_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
2	estudio	estudio	NCMS000	C0557651	medio_ambiente	569-576	101_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
3	de	de	SPS00	C0332285	atributo	577-579	101_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
4	anticuerpos	anticuerpo	NCMP000	C0003241	sustancia	580-591	101_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
5	irregulares	irregular	AQ0CP0	C0205271	calificador	592-603	101_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
6	es	ser	VSIP3S0	-	-	604-606	101_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
7	positivo	positivo	AQ0MS0	C1446409	calificador	607-615	101_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
8	en	en	SPS00	C1720294#C0332285	calificador#atributo	616-618	101_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
9	forma	forma	NCFS000	C0348078	atributo	619-624	101_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
10	de	de	SPS00	C0332285	atributo	625-627	101_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
11	panaglutinina	panaglutinina	AQ0FS00	-	-	628-641	101_QUEST_clinical_caseMIR	SENT5	B-Grp_Medicamento	-	-	-	-
12	,	,	Fc	-	-	641-642	101_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
13	dificultando	dificultar	VMG0000	-	-	643-655	101_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
14	la	el	DA0FS0	-	-	656-658	101_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
15	prueba	prueba	NCFS000	-	-	659-665	101_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
16	cruzada	cruzar	VMP00SF	-	-	666-673	101_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
17	.	.	Fp	-	-	673-674	101_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-

1	¿	¿	Fia	-	-	675-676	101_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
2	Cuál	cuál	PT0CS000	-	-	676-680	101_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
3	sería	ser	VSIC1S0	-	-	681-686	101_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
4	su	su	DP3CS0	-	-	687-689	101_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
5	sospecha	sospecha	NCFS000	C0750491	calificador	690-698	101_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
6	y	y	CC	C1706368	calificador	699-700	101_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
7	el	el	DA0MS0	-	-	701-703	101_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
8	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	704-715	101_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
9	más	más	RG	C0205172	calificador	716-719	101_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
10	adecuado	adecuar	VMP00SM	-	-	720-728	101_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
11	?	?	Fit	-	-	728-729	101_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-
12	.	.	Fp	-	-	729-730	101_QUEST_clinical_caseMIR	SENT6	-	-	-	-	-

